SALT POINT STRATEGIES

Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Apr 19, 2025

Lobbying activity 1

Pharmacy

Non-opioid pain relief and drug pipeline issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem